Donggu Cholecalciferol Injection 300,000 IU

Adult administration

Administer 300,000 IU of cholecalciferol via intramuscular injection. Ensure the annual dosage does not exceed 600,000 IU as cholecalciferol.

This medication is an injectable form of vitamin D, and one must verify the total amount of vitamin D when consuming other therapeutic agents or fortified foods that contain vitamin D to avoid excess dosage. Regular testing of serum calcium levels is necessary, and this medication should be discontinued if calcium levels exceed the normal range. In cases of high calcium intake, it is important to regularly monitor calcium levels in blood and urine. This medication should not be used in certain patients, such as those with allergies to any component of this medication, hypercalcemia, hypercalciuria, calcium stones, renal disease, non-ambulatory patients, patients with specific conditions, and pregnant or breastfeeding women. While using this medication, various side effects such as headache, fatigue, myalgia, digestive issues, dehydration, hypertension, renal issues, skin rashes, etc. may occur; if any unusual symptoms arise, immediate consultation with a healthcare provider is necessary. Regular checks of serum vitamin D and parathyroid hormone levels should be conducted to prevent side effects from overdose. Patients with compromised renal function, elderly individuals, and those taking certain medications should closely monitor renal function and calcium levels through blood tests. This medication can interact with other drugs, so caution is needed when taken alongside anticonvulsants, diuretics, antacids, warfarin, etc., and it must be reported to healthcare providers. Pregnant or breastfeeding women should not use this medication, as prolonged overdose may result in side effects in the fetus or newborn. The safety in children has not been sufficiently established, and special caution is required when administering to children. In the case of overdose, one should immediately stop administering this medication, reduce calcium intake, increase hydration, and seek treatment as directed by a healthcare provider if necessary. Do not mix this medication with other drugs; it should be used quickly after opening the ampoule, and any remaining drug should be discarded. Store this medication in a sealed container to avoid exposure to air and light, keep it at room temperature between 1 to 30 degrees Celsius for prolonged efficacy.

Serious side effects

Renal impairment

Mild side effects

Headache, weakness, fatigue, myalgia, loss of appetite, weight loss, growth retardation, nausea, vomiting, constipation, diarrhea, polydipsia, polyuria, dehydration, hypertension, calcium stones, tissue calcification in kidneys and blood vessels, excessive bone calcification, arrhythmia, psychological symptoms, awareness disorders, arthralgia, myasthenia, drowsiness, azotemia, hypersensitivity reactions, thirst, confusion, bloating, abdominal pain, metallic taste, xerostomia, rash, itching, hypercalciuria, hypercalcemia.

This medication should be stored in a sealed container to prevent exposure to air and light, ideally at room temperature between 1 to 30 degrees Celsius. This will help maintain the medication's efficacy over time.

Appearance

A yellowish cholecalciferol solution that is colorless to green, contained in a brown glass ampoule.

Package unit

1 mL/ampoule x 5 ampoules